The Chan Zuckerberg Initiative, run by Facebook founder Mark Zuckerberg and his wife Priscilla Chan, has purchased Canadian artificial intelligence start-up Meta, which uses A.I. to read and comprehend scientific papers and then provide insights to researchers, as part of its mission to eradicate disease around the world. Meta capabilities will be unified in a tool made available for free to scientists. Meta co-founder and chief executive Sam Molyneux said in a statement, "We are very excited about what lies ahead." The start-up now joins an organization started by Zuckerberg and his wife, which in September, pledged $3 billion over the next decade in an effort to end all disease, pouring some of the Facebook founder's fortune into innovative research to meet the goal. "This is a big goal," said Zuckerberg at a San Francisco event where he announced the effort of the philanthropic organization established by Mark and his wife in 2015.
The Chan Zuckerberg initiative, the philanthropic foundation launched by Facebook CEO Mark Zuckerberg and his wife, Priscilla Chan, announced that it's acquiring artificial intelligence startup Meta. Based in Toronto, Meta built a search engine for the scientific community that parses through millions of academic research papers and presents the latest and most relevant results to users. "Meta uses artificial intelligence to analyze and connect insights across millions of papers," Cori Bargmann, Chan Zuckerberg's president of science, and Brian Pinkerton, the group's president of technology, wrote in a Facebook post. "It seeks out the most relevant or impactful studies in a scientific area the moment they are published, and finds patterns in the literature on a scale that no human being could accomplish alone."The Chan Zuckerberg initiative plans to upgrade the tool to make it more powerful and then offer it for free to all researchers.
The Chan Zuckerberg Initiative is getting some help from artificial intelligence. The philanthropic organization, founded by Facebook (fb) CEO Mark Zuckerberg and his wife Priscilla Chan in 2015, will buy Meta, a startup focusing on artificial intelligence and related data analytic technology in the healthcare industry. The deal was disclosed in a Facebook post Monday by Chan Zuckerberg Initiative president of science Cornelia Bargmann and the organization's CTO Brian Pinkerton. Terms of the deal were not revealed. Meta specializes in using artificial intelligence technologies like natural language processing and machine learning to sift through millions of scientific and technology papers and identify which papers should presumably be most important to health-care professionals.
The organization, owned by Zuckerberg and wife Dr. Priscilla Chan, announced on Monday it is acquiring AI firm Meta. The deal, which marks the organization's first acquisition, was purchased for an undisclosed amount. Meta uses AI to analyze millions of scientific papers and help scientists find relevant materials and patterns in data. The group plans to provide Meta's tools for free to all researchers. "Meta will help scientists learn from others' discoveries in real time, find key papers that may have gone unnoticed, or even predict where their field is headed," Cori Bargmann, president of science, and Brian Pinkerton, CTO of the Chan Zuckerberg Initiative, wrote in a post on Facebook.
The Chan Zuckerberg Inititative, a philanthropic initiative from Facebook CEO Mark Zuckerberg and his wife Dr. Priscilla Chan, a pediatrician, has acquired a startup, Meta, focused on using AI and machine learning to sift through recently published scientific studies. The terms of the acquisition were undisclosed. Announced in September, the Chan Zuckerberg Initiative is a limited liability company focused on the ambitious goal to "cure, prevent, or manage all diseases by the end of the century." At least $3 billion will be allocated toward that goal, all coming out of Chan and Zuckerberg's Facebook shares. "In science, peer-reviewed articles are the medium for the global conversation among researchers, and they represent the foundational reference point by which we judge what is known, where science is going, and what to work on next," Meta CEO Sam Molyneux, who cofounded the startup with his sister Amy, wrote in a blog post announcing the acquisition.